Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies

Discussion in 'Other Health News and Research' started by Dolphin, Dec 8, 2014.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    10,733
    Likes:
    28,337
    Probably a minority interest

    Free full text: http://www.trialsjournal.com/content/15/1/456

     
    Sasha, Simon, Valentijn and 3 others like this.
  2. Esther12

    Esther12 Senior Member

    Messages:
    8,449
    Likes:
    28,526
    Almost shouldn't need saying... lots of CFS research shows that it does.
     
    Dolphin, Sasha, Simon and 1 other person like this.
  3. Valentijn

    Valentijn Senior Member

    Messages:
    14,281
    Likes:
    45,878
    So if you can't blind the assessors, at least use objective indications for outcomes and adverse reactions :rolleyes:
     

See more popular forum discussions.

Share This Page